Stockholders' Equity |
3 Months Ended |
|---|---|
Mar. 31, 2025 | |
| Stockholders' Equity | |
| Stockholders' Equity | 8. Stockholders’ Equity Common Stock During the year ended December 31, 2024, the Company’s board of directors adopted, and its stockholders approved, an increase in the total authorized shares of common stock from 100,000,000 to 150,000,000 shares with a par value of $0.001 per share. At-The-Market Sales Facility In March 2022, the Company filed a shelf registration statement with the SEC, which was declared effective on April 22, 2022. On April 28, 2022, the Company entered into an at-the-market sales agreement (the Sales Agreement) with Cowen and Company, LLC. Under the Sales Agreement, the Company may sell up to $100.0 million worth of shares of common stock. There were no shares issued under the 2022 Sales Agreement during the year ended December 31, 2024 or the three months ended March 31, 2025. As of March 31, 2025, approximately $66.0 million remained available to be sold under the terms of the Sales Agreement. The shelf registration statement expired on April 28, 2025.
|